SEC Filing Details
Document Details
Form
Filing Date
Jan 20, 2021
Document Date
Jan 20, 2021
Form Description
Registration of up to an additional 20% of securities for any offering registered on a S-3
Filing Group
Registration Statements
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc.